Trials / Terminated
TerminatedNCT02655666
Qingdao: Insulin Pump Follow-Up Program
Qingdao: Insulin Pump Follow-up Program
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 16 (actual)
- Sponsor
- Medtronic MiniMed, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to observe/ collect clinical data, subject users' feedback, and device data to better understand the real-life usage and acceptance of the 722 Pump in type 1 diabetes subjects,\<18 years of age, and the role of insulin pump therapy in Qingdao,China.
Detailed description
This is a prospective, multi-center, non-randomized and noninterventional post-market release study. Subjects will participate in 2 phases with each phase requiring the subject to use the continuous subcutaneous insulin infusion (CSII) pump over the course of the study. During the study, subjects and parent or legal guardian will be trained to wear the glucose sensor in the abdominal area for 3 days to transmit real-time (RT) data to the pump. The duration of each study phase is approximately 6 months.
Conditions
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2016-01-14
- Last updated
- 2019-07-11
- Results posted
- 2018-09-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02655666. Inclusion in this directory is not an endorsement.